This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Read, G S Articles by Keller, P M Search for Related Content PubMed PubMed Citation Articles by Read, G S Articles by Keller, P M

 Previous Article  |  Next Article 

J Virol. 1980 July; 35(1): 105-113

Genetic studies of cell fusion induced by herpes simplex virus type 1.

ABSTRACT

Eight cell fusion-causing syn mutants were isolated from the KOS strain of herpes simplex virus type 1. Unlike the wild-type virus, the mutants produced plaques containing multinucleated cells, or syncytia. Fusion kinetics curves were established with a Coulter Counter assay for the mutants and wild-type virus in single infections of human embryonic lung (HEL) cells, for the mutants and wild-type virus in mixed infections (dominance test), and for pairs of mutants in mixed infections (complementation test). In single infections, fusion began 4 to 6 h after infection and proceeded with an exponential decrease in the number of small single cells. At some later time that was characteristic of the mutant, there was a significant reduction in the rate of fusion for all but possibly one of the mutants. Although the wild-type virus did not produce syncytial plaques, it did induce a small amount of fusion that stopped abruptly about 2 h after it started. These data are consistent with the hypothesis that both mutants and wild type induce an active fusion inducer and that the activity of this inducer is subsequently inhibited. The extent of fusion is apparently determined by the length of the interval during which the fusion inducer is active. That fusion is actively inhibited in wild-type infections is indicated by the observation that syn mutant-infected cells fused more readily with uninfected cells than with wild-type infected cells. Fusion was decreased in mixed infections with the mutants and wild-type virus, but the mutants displayed a codominant fusion phenotype. Fusion was not decreased in mixed infection with pairs of mutants, indicating that the mutants, with one possible exception, are members of the same complementation group. A linkage map was established for six of the mutants by analysis of recombination frequencies.

This article has been cited by other articles:

• Nakamori, M., Fu, X., Meng, F., Jin, A., Tao, L., Bast, R. C. Jr., Zhang, X. (2003). Effective Therapy of Metastatic Ovarian Cancer with an Oncolytic Herpes Simplex Virus Incorporating Two Membrane Fusion Mechanisms. Clin. Cancer Res. 9: 2727-2733 [Abstract] [Full Text]  
• Foster, T. P., Alvarez, X., Kousoulas, K. G. (2002). Plasma Membrane Topology of Syncytial Domains of Herpes Simplex Virus Type 1 Glycoprotein K (gK): the UL20 Protein Enables Cell Surface Localization of gK but Not gK-Mediated Cell-to-Cell Fusion. J. Virol. 77: 499-510 [Abstract] [Full Text]  
• Wong, K. T., Shieh, W.-J., Kumar, S., Norain, K., Abdullah, W., Guarner, J., Goldsmith, C. S., Chua, K. B., Lam, S. K., Tan, C. T., Goh, K. J., Chong, H. T., Jusoh, R., Rollin, P. E., Ksiazek, T. G., Zaki, S. R. (2002). Nipah Virus Infection: Pathology and Pathogenesis of an Emerging Paramyxoviral Zoonosis. Am. J. Pathol. 161: 2153-2167 [Abstract] [Full Text]  
• Fu, X., Zhang, X. (2002). Potent Systemic Antitumor Activity from an Oncolytic Herpes Simplex Virus of Syncytial Phenotype. Cancer Res. 62: 2306-2312 [Abstract] [Full Text]  
• Foster, T. P., Rybachuk, G. V., Kousoulas, K. G. (2001). Glycoprotein K Specified by Herpes Simplex Virus Type 1 Is Expressed on Virions as a Golgi Complex-Dependent Glycosylated Species and Functions in Virion Entry. J. Virol. 75: 12431-12438 [Abstract] [Full Text]  
• Mo, C., Holland, T. C. (1997). Determination of the Transmembrane Topology of Herpes Simplex Virus Type 1 Glycoprotein K (gK). J. Biol. Chem. 272: 33305-33311 [Abstract] [Full Text]